Quantcast

Latest TheraSphere Stories

2014-09-29 08:30:18

BONN, Germany, September 29, 2014 /PRNewswire/ -- Newly published European Society for Medical Oncology (ESMO) clinical guidelines for the treatment of metastatic colorectal cancer (mCRC) endorse radioembolisation, specifically with Yttrium-90 resin microspheres, as a clinically proven technology to "prolong time to liver tumour progression" in mCRC patients who have failed to respond to available chemotherapy options. SIR-Spheres Y-90 resin microspheres, the lead...

2014-09-09 12:26:46

Clinical Trials Will Continue to Play a Key Role in this Growing Market, According to Findings from Decision Resources Group BURLINGTON, Mass., Sept. 9, 2014 /PRNewswire/ -- Decision Resources Group finds that the United States interventional oncology device market will see strong growth, reaching a value of $760 million by 2023. Rising cancer incidence rates combined with the ineffectiveness of chemotherapy and demand for less invasive procedures will support interventional oncology device...

2014-08-11 16:28:32

In the news release, The Asia Pacific Transcatheter Embolization and Occlusion Device Market Will Be Driven By the Adoption of Flow-Diverting Devices and Radioembolization Spheres, issued 08-Jul-2014 by Decision Resources Group over PR Newswire, we are advised by the company that there have been changes to the Comments from Decision Resources Group Senior Analyst Sean Messenger. The complete, corrected release follows: The Asia Pacific Transcatheter Embolization and Occlusion Device Market...

2014-07-08 12:29:16

Australia Has the Strongest Presence of These Innovative Products, But Competitors Are Increasingly Focusing on China, According to Findings from Decision Resources Group BURLINGTON, Mass., July 8, 2014 /PRNewswire/ -- Decision Resources Group finds that the Asia Pacific market for transcatheter embolization and occlusion (TEO) devices--including Australia, China, South Korea and India--is a dynamic and fast-growing market, driven by the launch of novel products such as interventional...

2014-02-03 04:20:02

Tokyo, Feb 3, 2014 - (JCN Newswire) - Eisai Co., Ltd. announced today that it will launch the vascular embolization device DC Bead(R) (specially controlled medical device) in Japan on February 4.DC Bead contains hydrophilic microspheres made from cross-linked polyvinyl alcohol polymer. Developed by Biocompatibles UK Limited (Biocompatibles), a BTG International group company, as an intravascular embolization device, it is injected via catheter into targeted blood...


Word of the Day
abrosia
  • Wasting away as a result of abstinence from food.
The word 'abrosia' comes from a Greek roots meaning 'not' and 'eating'.